What is a stock summary page? Click here for an overview.
Business Description
Genoway SA
ISIN : FR0004053510
Compare
Compare
Traded in other countries / regions
ALGEN.FranceJEH.Germany IPO Date
2007-05-04Description
Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmaceutical industries and research industries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.76 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 2.06 | |||||
| Interest Coverage | 17.76 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.3 | |||||
| Beneish M-Score | -2.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.2 | |||||
| 3-Year EBITDA Growth Rate | 62.8 | |||||
| 3-Year Book Growth Rate | 17.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -27.02 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 16.72 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.65 | |||||
| 9-Day RSI | 40.99 | |||||
| 14-Day RSI | 38.94 | |||||
| 3-1 Month Momentum % | 5.52 | |||||
| 6-1 Month Momentum % | -9.72 | |||||
| 12-1 Month Momentum % | -17.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.99 | |||||
| Quick Ratio | 1.87 | |||||
| Cash Ratio | 0.56 | |||||
| Days Inventory | 71.79 | |||||
| Days Sales Outstanding | 101.09 | |||||
| Days Payable | 186.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.1 | |||||
| Shareholder Yield % | 6.66 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.26 | |||||
| Operating Margin % | 8.21 | |||||
| Net Margin % | 8.3 | |||||
| FCF Margin % | 20.54 | |||||
| ROE % | 10.35 | |||||
| ROA % | 5.71 | |||||
| ROIC % | 5.84 | |||||
| 3-Year ROIIC % | 179.6 | |||||
| ROC (Joel Greenblatt) % | 14.6 | |||||
| ROCE % | 7.72 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.38 | |||||
| Forward PE Ratio | 28.1 | |||||
| PE Ratio without NRI | 14.19 | |||||
| Shiller PE Ratio | 51.09 | |||||
| Price-to-Owner-Earnings | 5.35 | |||||
| PEG Ratio | 0.48 | |||||
| PS Ratio | 1.1 | |||||
| PB Ratio | 1.44 | |||||
| Price-to-Tangible-Book | 1.44 | |||||
| Price-to-Free-Cash-Flow | 5.06 | |||||
| Price-to-Operating-Cash-Flow | 3.32 | |||||
| EV-to-EBIT | 15.04 | |||||
| EV-to-EBITDA | 8.81 | |||||
| EV-to-Revenue | 1.24 | |||||
| EV-to-FCF | 6.01 | |||||
| Price-to-GF-Value | 0.53 | |||||
| Price-to-Projected-FCF | 1.34 | |||||
| Price-to-DCF (Earnings Based) | 1.14 | |||||
| Price-to-DCF (FCF Based) | 0.41 | |||||
| Price-to-Median-PS-Value | 0.76 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.47 | |||||
| Price-to-Graham-Number | 0.95 | |||||
| Price-to-Net-Current-Asset-Value | 6.85 | |||||
| Earnings Yield (Greenblatt) % | 6.65 | |||||
| FCF Yield % | 17.61 | |||||
| Forward Rate of Return (Yacktman) % | 21.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genoway SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 22.059 | ||
| EPS (TTM) (€) | 0.21 | ||
| Beta | 0.6 | ||
| 3-Year Sharpe Ratio | -0.2 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 22.95 | ||
| 14-Day RSI | 38.94 | ||
| 14-Day ATR (€) | 0.09102 | ||
| 20-Day SMA (€) | 2.8424 | ||
| 12-1 Month Momentum % | -17.93 | ||
| 52-Week Range (€) | 2.4 - 4.69 | ||
| Shares Outstanding (Mil) | 9.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genoway SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genoway SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genoway SA Frequently Asked Questions
What is Genoway SA(XPAR:ALGEN)'s stock price today?
The current price of XPAR:ALGEN is €2.81. The 52 week high of XPAR:ALGEN is €4.69 and 52 week low is €2.40.
When is next earnings date of Genoway SA(XPAR:ALGEN)?
The next earnings date of Genoway SA(XPAR:ALGEN) is .
Does Genoway SA(XPAR:ALGEN) pay dividends? If so, how much?
Genoway SA(XPAR:ALGEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers